Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-016703
Filing Date
2022-06-09
Accepted
2022-06-09 16:46:53
Documents
2
Period of Report
2022-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165480759498402.html 4  
1 FORM 4 wf-form4_165480759498402.xml 4 3886
2 WARREN POA ex-24.txt EX-24 3881
  Complete submission text file 0001628280-22-016703.txt   9222
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3891 RANCHERO DRIVE SUITE 150 ANN ARBOR MI 48108
Business Address
Warren Eric (Reporting) CIK: 0001916048 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35986 | Film No.: 221006508